Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea

[1]  B. Jönsson,et al.  Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea. , 2009, Journal of travel medicine.

[2]  E. Reisinger,et al.  Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom? , 2008, Travel medicine and infectious disease.

[3]  M. Quilici,et al.  A cluster of Vibrio cholerae O1 infections in French travelers to Rajasthan (India), May 2006. , 2008, Journal of travel medicine.

[4]  R. Steffen,et al.  Economic aspects of travelers' diarrhea. , 2008, Journal of travel medicine.

[5]  R. López-Gigosos,et al.  Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS. , 2007, Travel medicine and infectious disease.

[6]  L. Rombo,et al.  The true burden and risk of cholera: implications for prevention and control. , 2007, The Lancet. Infectious diseases.

[7]  M. Bissell.  Spectrum of Disease and Relation to Place of Exposure among Ill Returned TravelersFreedman DO, for the GeoSentinel Surveillance Network (Univ of Alabama at Birmingham; et al) N Engl J Med 354:119–130, 2006§ , 2007 .

[8]  U. Wiedermann,et al.  [Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea]. , 2007, Wiener medizinische Wochenschrift.

[9]  U. Wiedermann,et al.  Impfstoffe gegen Durchfallserkrankungen – am Beispiel der Impfstoffe gegen Reisediarrhoe und gegen Rotavirus , 2007, Wiener Medizinische Wochenschrift.

[10]  D. Lalloo,et al.  Oral cholera vaccines: use in clinical practice. , 2006, The Lancet. Infectious diseases.

[11]  P. Landry.  [Diarrhea and vaccines: current developments]. , 2006, Revue medicale suisse.

[12]  M. Levine.  Enteric infections and the vaccines to counter them: future directions. , 2006, Vaccine.

[13]  M. Kieny,et al.  A review of vaccine research and development: human enteric infections. , 2006, Vaccine.

[14]  J. Gascón.  Epidemiology, Etiology and Pathophysiology of Traveler’s Diarrhea , 2006, Digestion.

[15]  M. Cetron,et al.  Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.

[16]  U. Wiedermann,et al.  Vaccines against traveler's diarrhoea and rotavirus disease – a review , 2006, Wiener klinische Wochenschrift.

[17]  R. Steffen,et al.  Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. , 2006, Journal of travel medicine.

[18]  Eman Hassan,et al.  Recall Bias can be a Threat to Retrospective and Prospective Research Designs , 2005 .

[19]  J. Holmgren,et al.  Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. , 2005, Current opinion in immunology.

[20]  S. Calderwood,et al.  Cholera vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  M. Thomson,et al.  Treatment of traveller's diarrhoea. Economic aspects. , 1996, PharmacoEconomics.

[22]  H. Dupont,et al.  Travelers' diarrhea: approaches to prevention and treatment. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Cossar,et al.  Epidemiology of travel. , 1993, British medical bulletin.

[24]  A. Siitonen,et al.  Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine , 1991, The Lancet.

[25]  D. Sack,et al.  Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. , 1988, The Journal of infectious diseases.

[26]  D. Sack,et al.  FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH , 1986, The Lancet.

[27]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[28]  G. Davidson,et al.  ROTAVIRUS INFECTIONS IN OBSTETRIC HOSPITALS , 1975, The Lancet.

[29]  C. Hastings.  THE NEW EQUITABLE LIFE ASSURANCE COMPANY. , 1854 .